The Biomanufacturing Blog

Subscribe Here!

Supplementing In-House Bioreactor Capacity to Run High-Throughput DOEs

A case study of a pharmaceutical client who supplemented in-house capacity with Culture's...

Launching Culture’s 5L Reactors: An Interview with CEO Will Patrick

As we launch our 5L bioreactors, our co-founder and CEO Will Patrick reflects on why this is such a...

Introducing a New Strain Screening Paradigm

How empowering strain engineering groups with Culture's cloud bioreactor capacity can accelerate R&D

From Tech Transfer to Data Analysis and Beyond: Culture’s BAM Team Partners with Clients from Scale-Down to Scale-Up

Diana Eng is the director of Culture’s Bioprocess Alliance Management (BAM) team where she...

Making Bioengineering a Reality: Culture Enables Sestina’s New SynBio Platform

The recent increase in consumer demand for sustainably made products has led to a surge in the...

How Culture Biosciences is Scaling Up: An Interview with Our First Employee

Get to know Collin Edington, Hardware Engineering Manager at Culture and our first employee. Collin...

The Global Biomanufacturing Capacity Problem

While you may be aware that synthetic biology is on the rise, you may not know that there’s a major...

When should I start using bioreactors?

Many of Culture’s clients have questions pertaining to the right time to transition to bioreactors...

How to De-Risk Bioprocess Scale-Up

Scaling up a bioprocess can be challenging, but thorough preparation for scale-up early in the...

3 Alternative Feeding Strategies to Improve Strain Performance

In addition to the multitude of different biological pathways and organism physiologies that can be...

1 2 3 4 5